SeLux Diagnostics, Inc.
Precision diagnostics for infectious diseases - Selux Diagnostics
Charlestown, United States · Founded 2016 · $149.3M raised
- Headquarters
- Charlestown, Massachusetts
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- seluxdx.com
- Total Funding
- $149.3M
- Last Round
- $48.0M Series DMar 2024
- Rounds
- 8
About
Selux Diagnostics is a Boston-based company developing precision diagnostics for infectious diseases and combating antimicrobial resistance. Its proprietary Next Generation Phenotyping (NGP) System delivers rapid, high-throughput antimicrobial susceptibility testing (AST) and minimum inhibitory concentration (MIC) results for clinical microbiology labs. By closing the gap between infection identification and susceptibility testing, Selux enables personalized treatment decisions that help halt the spread of antibiotic-resistant superbugs and preserve the efficacy of antibiotics. The company has received FDA Breakthrough Device Designation, FDA clearance for its NGP System, and BARDA funding in recognition of its potential to transform infectious disease treatment.
Summary
SeLux Diagnostics, Inc. is a Healthcare company based in Charlestown, United States, founded in 2016. It has raised $149.3M in total across 8 rounds, most recently a $48.0M Series D round in Mar 2024. Investors include Biomedical Advanced Research and Development Authority (BARDA), RA Capital Management and Christopher Herr.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Sign up to see all 9 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Biomedical Advanced Research and Development Authority (BARDA)
3 rounds
RA Capital Management
2 rounds
Christopher Herr
1 round
NIH
1 round
Northpond Ventures
2 rounds
Sands Capital
2 rounds
Schooner Capital
2 rounds
Asset Management Ventures
1 round
Bain Capital Life Sciences
1 round
Cofounders Capital
1 round
Polaris Partners
1 round
Section 32
1 round
Anne Wojcicki
1 round
Fusion Fund
1 round
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...